LD-2 disclosure · 4th Quarter - Report
ORGANOGENESIS INC.
via ORGANOGENESIS INC.
Client
- Name
- ORGANOGENESIS INC.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- ORGANOGENESIS INC.
- Description
- Biotechnology/Medical Device
- Location
- Canton, Massachusetts, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Medicare reimbursement policy for chronic wound healing products Physician Fee Schedule regulations regarding reimbursement for chronic wound healing product
LobbyistsARTHUR-PAUL PETROSINELLI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Food and Drug Administration policy on chronic wound healing products S. 4348 (FDASLA Act of 2002), regarding Food and Drug Administration policy on chronic wound healing products H.R. 7667 (Food and Drug Amendments of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 2617 (Consolidated Appropriations Act, 2023), Division FF, Title III, regarding Food and Drug Administration policy on chronic wound healing products
LobbyistsARTHUR-PAUL PETROSINELLI